Delineating the roles of the GPIIb/IIIa and GP-Ib-IX-V platelet receptors in mediating platelet adhesion to adsorbed fibrinogen and albumin

Biomaterials

Volumn 32, Issue 23, 2011, Pages 5365-5370

  Sivaraman, Balakrishnan ^a   Latour, Robert A ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b South   (United States)

Author keywords

Albumin; Blood compatibility; Fibrinogen; Platelet adhesion; Thrombosis

Indexed keywords

ALBUMIN; BLOOD COMPATIBILITY; FIBRINOGEN; PLATELET ADHESION; THROMBOSIS;

ADHESION; ADSORPTION; BIOLOGICAL MATERIALS; BIOMATERIALS; MONOCLONAL ANTIBODIES; PROTEINS; SELF ASSEMBLED MONOLAYERS;

PLATELETS;

ALBUMIN; ARGINYLGLYCYLASPARTIC ACID; BIOMATERIAL; FIBRINOGEN; FIBRINOGEN RECEPTOR; LACTATE DEHYDROGENASE; MONOCLONAL ANTIBODY; PLASMA PROTEIN; SELF ASSEMBLED MONOLAYER; TIROFIBAN;

ADSORPTION; ARTICLE; BIOCOMPATIBILITY; CARDIOVASCULAR DISEASE; CIRCULAR DICHROISM; CONTROLLED STUDY; ENZYME ASSAY; HUMAN; HUMAN CELL; PLASMA; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; THROMBOCYTE ADHESION; THROMBOSIS;

ADSORPTION; ANTIBODIES, MONOCLONAL; CIRCULAR DICHROISM; FATTY ALCOHOLS; FIBRINOGEN; GOLD; HUMANS; PLATELET ADHESIVENESS; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PLATELET MEMBRANE GLYCOPROTEINS; PROTEIN CONFORMATION; PROTEIN STRUCTURE, SECONDARY; SERUM ALBUMIN; SILICONES; SULFHYDRYL COMPOUNDS; TYROSINE;

EID: 79956320907     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.04.011     Document Type: Article

References (40)

1. Gorbet M.B., Sefton M.V. Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. Biomaterials 2004, 25:5681-5703.
2. Blockmans D., Deckmyn H., Vermylen J. Platelet activation. Blood Rev 1995, 9:143-156.
3. Clemetson K.J., Clemetson J.M. Platelet receptors. Platelets 2007, 117-144. Elsevier Science. 2nd ed. A.D. Michelson (Ed.).
4. Varga-Szabo D., Pleines I., Nieswandt B. Cell adhesion mechanisms in platelets. Arterioscler Thromb Vasc Biol 2008, 28:403-412.
5. Shattil S.J., Kashiwagi H., Pampori N. Integrin signaling: the platelet paradigm. Blood 1998, 91:2645-2657.
6. Ruggeri Z.M. Platelets in atherothrombosis. Nat Med 2002, 8:1227-1234.
7. Springer T.A., Zhu J.H., Xiao T. Structural basis for distinctive recognition of fibrinogen gamma C peptide by the platelet integrin alpha(IIb)beta(3). J Cell Biol 2008, 182:791-800.
8. Nurden A.T. Glanzmann thrombasthenia. Orphanet J Rare Dis 2006, 1:1-10.
9. Ruggeri Z.M. Structure and function of von Willebrand factor. Thromb Haemost 1999, 82:576-584.
10. Savage B., Almus-Jacobs F., Ruggeri Z.M. Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow. Cell 1998, 94:657-666.
11. Ruggeri Z.M. von Willebrand factor. J Clin Invest 1997, 99:559-564.
12. Andrews R.K., Berndt M.C. Platelet physiology and thrombosis. Thromb Res 2004, 114:447-453.
13. Lecut C., Schoolmeester A., Kuijpers M.J.E., Broers J.L.V., van Zandvoort M., Vanhoorelbeke K., et al. Principal role of glycoprotein VI in alpha 2 beta 1 and alpha IIb beta 3 activation during collagen-induced thrombus formation. Arterioscler Thromb Vasc Biol 2004, 24:1727-1733.
14. Cauwenberghs N., Meiring M., Vauterin S., van Wyk V., Lamprecht S., Roodt J.P., et al. Antithrombotic effect of platelet glycoprotein Ib-blocking monoclonal antibody Fab fragments in nonhuman primates. Arterioscler Thromb Vasc Biol 2000, 20:1347-1353.
15. Cauwenberghs N., Vanhoorelbeke K., Vauterin S., Westra D.F., Rome G., Huizinga E.G., et al. Epitope mapping of inhibitory antibodies against platelet glycoprotein Ib alpha reveals interaction between the leucine-rich repeat N-terminal and C-terminal flanking domains of glycoprotein Ib alpha. Blood 2001, 98:652-660.
16. Vanhoorelbeke K., Ulrichts H., Van de Walle G., Fontayne A., Deckmyn H. Inhibition of platelet glycoprotein Ib and its antithrombotic potential. Curr Pharm Des 2007, 13:2684-2697.
17. Farrell D.H., Thiagarajan P., Chung D.W., Davie E.W. Role of fibrinogen alpha and gamma chain sites in platelet aggregation. Proc Natl Acad Sci USA 1992, 89:10729-10732.
18. Horbett T.A., Lew K.R. Residence time effects on monoclonal antibody binding to adsorbed fibrinogen. J Biomater Sci Polym Ed 1994, 6:15-33.
19. Sivaraman B., Latour R.A. The relationship between platelet adhesion on surfaces and the structure versus the amount of adsorbed fibrinogen. Biomaterials 2010, 31:832-839.
20. Sivaraman B., Latour R.A. The adherence of platelets to adsorbed albumin by receptor-mediated recognition of binding sites exposed by adsorption-induced unfolding. Biomaterials 2010, 31:1036-1044.
21. Wu D.M., Meiring M., Kotze H.F., Deckmyn H., Cauwenberghs N. Inhibition of platelet glycoprotein Ib, glycoprotein IIb/IIIa, or both by monoclonal antibodies prevents arterial thrombosis in baboons. Arterioscler Thromb Vasc Biol 2002, 22:323-328.
22. Honda S., Tomiyama Y., Aoki T., Shiraga M., Kurata Y., Seki J., et al. Association between ligand-induced conformational changes of integrin alpha(IIb)beta(3) and alpha(IIb)beta(3)-mediated intracellular Ca2+ signaling. Blood 1998, 92:3675-3683.
23. Bain C.D., Troughton E.B., Tao Y.T., Evall J., Whitesides G.M., Nuzzo R.G. Formation of monolayer films by the spontaneous assembly of organic thiols from solution onto gold. J Am Chem Soc 1989, 111:321-335.
24. Gooding J.J., Mearns F., Yang W.R., Liu J.Q. Self-assembled monolayers into the 21(st) century: recent advances and applications. Electroanalysis 2003, 15:81-96.
25. Fears K.P., Sivaraman B., Powell G.L., Wu Y., Latour R.A. Probing the conformation and orientation of adsorbed enzymes using side-chain modification. Langmuir 2009, 25:9319-9327.
26. Coelho M.A.N., Vieira E.P., Motschmann H., Mohwald H., Thunemann A.F. Human serum albumin on fluorinated surfaces. Langmuir 2003, 19:7544-7550.
27. Damodaran S. In situ measurement of conformational changes in proteins at liquid interfaces by circular dichroism spectroscopy. Anal Bioanal Chem 2003, 376:182-188.
28. Greenfield N.J. Using circular dichroism spectra to estimate protein secondary structure. Nat Protoc 2006, 1:2876-2890.
29. Grunkemeier J.M., Tsai W.B., Horbett T.A. Co-adsorbed fibrinogen and von Willebrand factor augment platelet procoagulant activity and spreading. J Biomater Sci Polym Ed 2001, 12:1-20.
30. Van de Walle G.R., Schoolmeester A., Iserbyt B.F., Cosemans J., Heemskerk J.W.M., Hoylaerts M.F., et al. Activation of alpha(IIb)beta(3) is a sufficient but also an imperative prerequisite for activation of alpha(2)beta(1) on platelets. Blood 2007, 109:595-602.
31. Sivaraman B., Fears K.P., Latour R.A. Investigation of the effects of surface chemistry and solution concentration on the conformation of adsorbed proteins using an improved circular dichroism method. Langmuir 2009, 25:3050-3056.
32. Akaike T., Sakurai Y., Kosuge K., Senba Y., Kuwana K., Miyata S., et al. Study on the interaction between plasma-proteins and polyion complex by circular-dichroism and ultraviolet spectroscopy. Kobunshi Ronbunshu 1979, 36:217-222.
33. Qiu J., Lee H., Zhou C. Analysis of guanidine in high salt and protein matrices by cation-exchange chromatography and UV detection. J Chromatogr A 2005, 1073:263-267.
34. de Feijter J.A., Benjamins J., Veer F.A. Ellipsometry as a tool to study the adsorption behavior of synthetic and biopolymers at the air-water interface. Biopolymers 1978, 17:1759-1772.
35. Sreerama N., Woody R.W. Estimation of protein secondary structure from circular dichroism spectra: comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set. Anal Biochem 2000, 287:252-260.
36. Andrade J.D., Hlady V. Protein adsorption and materials biocompatibility: a tutorial review and suggested hypotheses. Adv Polym Sci 1986, 79:1-63.
37. Roach P., Farrar D., Perry C.C. Interpretation of protein adsorption: surface-induced conformational changes. J Am Chem Soc 2005, 127:8168-8173.
38. Latour R.A. Biomaterials: protein-surface interactions. The encyclopedia of biomaterials and bioengineering: informa healthcare 2008, 270-284. G.E. Wnek, G.L. Bowlin (Eds.).
39. Cook J.J., Bednar B., Lynch J.J., Gould R.J., Egbertson M.S., Halczenko W., et al. Tirofiban (Aggrastat (R)). Cardiovasc Drug Rev 1999, 17:199-224.
40. Lele M., Sajid M., Wajih N., Stouffer G.A. Eptifibatide and 7E3, but not tirofiban, inhibit alpha(v)beta(3) integrin-mediated binding of smooth muscle cells to thrombospondin and prothrombin. Circulation 2001, 104:582-587.